- 英文名称
- Escin IB
- 分子式
- C55H86O24
- 分子量
- 1131.26
- 中文别名
- 七叶皂苷Ib; 七叶皂苷B; 七叶皂苷IB, 来源于娑罗子; 七叶皂苷B(IB); 七叶皂苷B(ⅠB); (2S,3S,4S,5R,6R)-6-(((3S,4S,4aR,6aR,6bS,8R,8aR,9R,10R,12aS,14aR,14bR)-9-乙酰氧基-8-羟基-4,8a-双(羟甲基)-4,6a,6b,11,11,14b-六甲基-10-(((Z)-2-甲基丁-2-烯酰基)氧基)-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-二十氢苉-3-基)氧基)-4-羟基-3,5-双(((2S,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟甲基)四氢-2H-吡喃-2-基)氧基)四氢-2H-吡喃-2-羧酸; Aescin IB; Aescin B; Escin-IB; (3β,16α,21β,22α)-22-Acetoxy-16,24,28-trihydroxy-21-{[(2Z)-2-methyl-2-butenoyl]oxy}olean-12-en-3-yl β-D-glucopyranosyl-(1->2)-[β-D-glucopyranosyl-(1->4)]-β-D-glucopyranosiduronic acid; (3β,16α,21β,22α)-22-Acetoxy-16,24,28-trihydroxy-21-{[(2Z)-2-methylbut-2-enoyl]oxy}olean-12-en-3-yl β-D-glucopyranosyl-(1->2)-[β-D-glucopyranosyl-(1->4)]-β-D-glucopyranosiduronic acid; EINECS 247-619-4; 3-<2''-(β-D-glucopyranosido)-4'-(β-D-glucopyranosido)-β-D-glucuronopyranosido>-21-β-angeloyl-22-α-acetylprotoescigenin; Escin Impurity 2（Escin Ib）; beta-d-Glucopyranosiduronic acid, [3beta,16alpha,21beta(Z),22alpha]-22-(acetyloxy)-16,24,28-trihydroxy-21-[(2-methyl-1-oxo-2-butenyl)oxy]olean-12-en-3-yl O-beta-d-glucopyranosyl-(1->2)-O-[beta-d-glucopyranosyl-(1->4)]-; Escin IB(Aescin IB); 22α-(Acetyloxy)-16α,24,28-trihydroxy-21β-[[(Z)-2-methyl-1-oxo-2-butenyl]oxy]oleana-12-ene-3β-yl 4-O-[2-O-(β-D-gluco-hexopyranosyl)-β-D-gluco-hexopyranosyl]-β-D-gluco-hexopyranosiduronic acid
- 用途
- 七叶皂苷IB可用作有机合成中间体和医药中间体，可用于实验室研发过程和化工生产过程中，主要作为分析对照品和标准品；Escin IB是一种从马栗子(Aesculus hippocastanum)种子的皮和胚乳中分离出的皂苷，对pancreatic lipase活性有抑制作用。
